Richard B. Lanman
Director/Board Member at CirculoGene Theranostics, Inc.
Active connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Michael V. Mullen | M | - |
Atherotech, Inc.
 Atherotech, Inc. Medical/Nursing ServicesHealth Services Atherotech, Inc. operates a clinical reference laboratory that specializes in cardiometabolic testing and disease management solutions. It offers VAP+ (Vertical Auto Profile) Lipid Panel that enables clinicians to stratify a patient’s cardiovascular risk and deliver personalized treatment strategies to improve health outcomes. The firm also provides other lab tests and services; and consulting and education to healthcare providers and patients. The company was founded by Roseanne Varner and Jere Segrest in 1996 and is headquartered in Birmingham, AL.
CirculoGene Theranostics, Inc.
 CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | 23 years |
| John Beaver | M | 62 | 7 years | |
| Scott Rezek | M | - |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
| Jennifer Brighton | F | 53 | 3 years | |
| Kenneth Yale | M | 67 | 2 years | |
| Steven Sandor | M | 44 | 5 years | |
| Ian Clark | M | 62 | 8 years | |
| Martha Somerman | M | - | 3 years | |
| Karin Eastham | F | 74 | 12 years | |
| Kathleen O'Loughlin | M | 73 | 3 years | |
| Lou Apicella | M | - |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
| James E. Cantrell | M | - |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
| Robert P. Gasparini | M | 70 |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | 2 years |
| Richard T. Kloos | M | - | 12 years | |
| Stephen Eck | M | 69 |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
| Amelia Merrill | F | 52 | 7 years | |
| Darya Chudova | M | 50 | 9 years | |
| Daniel Coleman | M | - |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
| Chris Silvers | M | - | 6 years | |
| Daniel Bibb Coleman | M | 59 |
CirculoGene Theranostics, Inc.
CirculoGene Theranostics, Inc. Medical SpecialtiesHealth Technology CirculoGene Theranostics LLC operates as a molecular diagnostics company. It develops test for deoxyribonucleic acid liquid biopsies. It offers next-generation sequencing (NGS) method to provide full genomic load analysis, enabling accurate data to help clinicians and their patients. The company was founded by Chen-Hsiung Yeh in 2015 and is headquartered in Birmingham, AL. | - |
Connections Chart
Multi-company connection
Former connections
| Name | Gender | Age | Linked companies | Collaboration |
|---|---|---|---|---|
| Risa Stack | M | 55 | 2 years | |
| Christopher Hall | M | 55 | 9 years | |
| Shelly Guyer | F | 63 | 3 years | |
| Todd A. Norbe | M | 57 | 3 years | |
| Harold C. Flynn | M | 58 | 3 years | |
| Brendan O'Connell | M | 47 | 12 years | |
| Robert Monroe | M | - | - | |
| Garrett Sato | M | 63 | 3 years | |
| Lyssa Friedman | F | - | 6 years | |
| Dipchand Nishar | M | 54 | 2 years | |
| Jess Roper | M | 59 | 6 years | |
| Elaine C. Wagner | M | 69 | 4 years | |
| Bahija Jallal | M | 62 | 3 years | |
| Aaref Hilaly | M | 53 | 5 years | |
| Julie A. Brooks | F | 78 | - | |
| Michael C. DiTolla | M | 59 | 2 years | |
| James R. Talevich | M | 73 | 5 years | |
| David J. Foster | M | 66 |
diaDexus, Inc. /Old/
 diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 3 years |
| Frederic Moll | M | 72 | 4 years | |
| Bill Getty | M | - | 6 years | |
| Carol Gomez Summerhays | M | 70 | 2 years | |
| Jesse I. Treu | M | 76 | - | |
| Stanley Meresman | M | 77 | 4 years | |
| Duncan Thomas Powell | M | 54 | - | |
| Leena Das-Young | F | 62 | 1 years | |
| Natasha Kehimkar | F | - | 2 years | |
| Ryan Meardon | M | 44 | 9 years | |
| Ashish Kheterpal | M | - | - | |
| John Hanna | M | 44 | 10 years | |
| Jonathan Lord | M | 69 | 4 years | |
| John Andy Thorson | M | 61 | 1 years | |
| Morteza Minaee | M | - | - | |
| Joseph L. Rotino | M | 71 | 2 years | |
| Dee Jay A. Mailer | F | - |
Kaiser Permanente Washington Health Research Institute
 Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Kaiser Permanente Washington Health Research Institute is a non profit organization that provides healthcare plans and services. It focuses on total health of its members and guided by personal physicians, specialists, and team of caregivers. Its expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, care delivery, and chronic disease management. The company was founded in 1983 and is headquartered in Seattle, WA. | 13 years |
| William Winkenwerder | M | 69 |
Kaiser Permanente Washington Health Research Institute
Kaiser Permanente Washington Health Research Institute Hospital/Nursing ManagementHealth Services Kaiser Permanente Washington Health Research Institute is a non profit organization that provides healthcare plans and services. It focuses on total health of its members and guided by personal physicians, specialists, and team of caregivers. Its expert and caring medical teams are empowered and supported by industry-leading technology advances and tools for health promotion, disease prevention, care delivery, and chronic disease management. The company was founded in 1983 and is headquartered in Seattle, WA. | 3 years |
| Derek A. Bertocci | M | 70 | 4 years | |
| Michael Goller | M | 49 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 5 years |
| Kelvin Neu | M | 50 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 5 years |
| Karen S. Wright | F | 69 | 3 years | |
| Mohan S. Iyer | M | - |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 8 years |
| Charles W. Patrick | M | 69 |
diaDexus, Inc. /Old/
diaDexus, Inc. /Old/ Medical SpecialtiesHealth Technology diaDexus is a privately held biotechnology company that is focused on the discovery, development and commercialization of novel, patent protected diagnostic products with high clinical value. diaDexus makes a difference by developing innovative products with clinical value to address significant unmet medical needs in the cardiovascular field. | 3 years |
| Samuel D. Colella | M | 84 | 8 years | |
| James Azzaro | M | - | 4 years |
Statistics
| Country | Connections | % of total |
|---|---|---|
| United States | 63 | 100.00% |
Age of Connections
Active
Past
Male
Female
Members of the board
Executives
Origin of connections
- Stock Market
- Insiders
- Richard B. Lanman
- Personal Network
